Arthroplasty rates are increased among us patients with systemic lupus erythematosus: 1991-2005

Christina Mertelsmann-Voss, Leonard Lyman Stephen, Ting Jung Pan, Susan Goodman, Mark P. Figgie, Lisa A. Mandl

研究成果: ジャーナルへの寄稿記事

23 引用 (Scopus)

抄録

Objective:To evaluate population-based systemic lupus erythematosus (SLE) arthroplasty rates and compare them with rates in patients with no inflammatory or autoimmune conditions.Methods: Administrative hospital discharge databases from 10 American states were used to compare knee, hip, and shoulder arthroplasty rates from 1991 to 2005 in patients with SLE and in patients with no inflammatory or autoimmune conditions. Results: Arthroplasties were performed on patients with SLE (n = 4253) and patients with noninflammatory conditions (n = 2,762,660). Arthroplasty rates for patients with noninflammatory conditions almost doubled from 1991 to 2005 (124.5 cases/100,000 persons vs 247.5/100,000; p < 0.001). A similar trend was observed for SLE (0.17/100,000 vs 0.38/100,000; p < 0.001). The mean age at arthroplasty in patients with noninflammatory conditions decreased (71.5 ± 11.8 vs 69.0 ± 12.0; p < 0.001), whereas the mean age in patients with SLE increased (47.3 ± 17.0 vs 56.8 ± 16.0; p < 0.001). When stratified by age and sex, arthroplasty in cases of SLE increased in all groups except for women < 44 years old. In 1991, osteonecrosis accounted for 53% and osteoarthritis (OA) 23% of cases of SLE; by 2005 this relationship had reversed, with osteonecrosis accounting for 24% and OA 61% of cases of SLE. Conclusion: From 1991 to 2005, arthroplasty rates increased in patients with SLE in similar proportions to overall joint replacement rates. The age of patients with SLE arthroplasty increased and fewer cases were due to osteonecrosis. These data suggest significant changes are occurring - patients with SLE are now living long enough to develop OA and are healthy enough to undergo elective surgery.

元の言語英語
ページ(範囲)867-874
ページ数8
ジャーナルJournal of Rheumatology
41
発行部数5
DOI
出版物ステータス出版済み - 1 1 2014

Fingerprint

Arthroplasty
Systemic Lupus Erythematosus
Osteonecrosis
Osteoarthritis
Replacement Arthroplasties
Hip
Knee
Databases

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology and Allergy
  • Immunology

これを引用

Arthroplasty rates are increased among us patients with systemic lupus erythematosus : 1991-2005. / Mertelsmann-Voss, Christina; Lyman Stephen, Leonard; Pan, Ting Jung; Goodman, Susan; Figgie, Mark P.; Mandl, Lisa A.

:: Journal of Rheumatology, 巻 41, 番号 5, 01.01.2014, p. 867-874.

研究成果: ジャーナルへの寄稿記事

Mertelsmann-Voss, Christina ; Lyman Stephen, Leonard ; Pan, Ting Jung ; Goodman, Susan ; Figgie, Mark P. ; Mandl, Lisa A. / Arthroplasty rates are increased among us patients with systemic lupus erythematosus : 1991-2005. :: Journal of Rheumatology. 2014 ; 巻 41, 番号 5. pp. 867-874.
@article{40210a4f4a5d48c5bab0358c28faeedb,
title = "Arthroplasty rates are increased among us patients with systemic lupus erythematosus: 1991-2005",
abstract = "Objective:To evaluate population-based systemic lupus erythematosus (SLE) arthroplasty rates and compare them with rates in patients with no inflammatory or autoimmune conditions.Methods: Administrative hospital discharge databases from 10 American states were used to compare knee, hip, and shoulder arthroplasty rates from 1991 to 2005 in patients with SLE and in patients with no inflammatory or autoimmune conditions. Results: Arthroplasties were performed on patients with SLE (n = 4253) and patients with noninflammatory conditions (n = 2,762,660). Arthroplasty rates for patients with noninflammatory conditions almost doubled from 1991 to 2005 (124.5 cases/100,000 persons vs 247.5/100,000; p < 0.001). A similar trend was observed for SLE (0.17/100,000 vs 0.38/100,000; p < 0.001). The mean age at arthroplasty in patients with noninflammatory conditions decreased (71.5 ± 11.8 vs 69.0 ± 12.0; p < 0.001), whereas the mean age in patients with SLE increased (47.3 ± 17.0 vs 56.8 ± 16.0; p < 0.001). When stratified by age and sex, arthroplasty in cases of SLE increased in all groups except for women < 44 years old. In 1991, osteonecrosis accounted for 53{\%} and osteoarthritis (OA) 23{\%} of cases of SLE; by 2005 this relationship had reversed, with osteonecrosis accounting for 24{\%} and OA 61{\%} of cases of SLE. Conclusion: From 1991 to 2005, arthroplasty rates increased in patients with SLE in similar proportions to overall joint replacement rates. The age of patients with SLE arthroplasty increased and fewer cases were due to osteonecrosis. These data suggest significant changes are occurring - patients with SLE are now living long enough to develop OA and are healthy enough to undergo elective surgery.",
author = "Christina Mertelsmann-Voss and {Lyman Stephen}, Leonard and Pan, {Ting Jung} and Susan Goodman and Figgie, {Mark P.} and Mandl, {Lisa A.}",
year = "2014",
month = "1",
day = "1",
doi = "10.3899/jrheum.130617",
language = "English",
volume = "41",
pages = "867--874",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "5",

}

TY - JOUR

T1 - Arthroplasty rates are increased among us patients with systemic lupus erythematosus

T2 - 1991-2005

AU - Mertelsmann-Voss, Christina

AU - Lyman Stephen, Leonard

AU - Pan, Ting Jung

AU - Goodman, Susan

AU - Figgie, Mark P.

AU - Mandl, Lisa A.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objective:To evaluate population-based systemic lupus erythematosus (SLE) arthroplasty rates and compare them with rates in patients with no inflammatory or autoimmune conditions.Methods: Administrative hospital discharge databases from 10 American states were used to compare knee, hip, and shoulder arthroplasty rates from 1991 to 2005 in patients with SLE and in patients with no inflammatory or autoimmune conditions. Results: Arthroplasties were performed on patients with SLE (n = 4253) and patients with noninflammatory conditions (n = 2,762,660). Arthroplasty rates for patients with noninflammatory conditions almost doubled from 1991 to 2005 (124.5 cases/100,000 persons vs 247.5/100,000; p < 0.001). A similar trend was observed for SLE (0.17/100,000 vs 0.38/100,000; p < 0.001). The mean age at arthroplasty in patients with noninflammatory conditions decreased (71.5 ± 11.8 vs 69.0 ± 12.0; p < 0.001), whereas the mean age in patients with SLE increased (47.3 ± 17.0 vs 56.8 ± 16.0; p < 0.001). When stratified by age and sex, arthroplasty in cases of SLE increased in all groups except for women < 44 years old. In 1991, osteonecrosis accounted for 53% and osteoarthritis (OA) 23% of cases of SLE; by 2005 this relationship had reversed, with osteonecrosis accounting for 24% and OA 61% of cases of SLE. Conclusion: From 1991 to 2005, arthroplasty rates increased in patients with SLE in similar proportions to overall joint replacement rates. The age of patients with SLE arthroplasty increased and fewer cases were due to osteonecrosis. These data suggest significant changes are occurring - patients with SLE are now living long enough to develop OA and are healthy enough to undergo elective surgery.

AB - Objective:To evaluate population-based systemic lupus erythematosus (SLE) arthroplasty rates and compare them with rates in patients with no inflammatory or autoimmune conditions.Methods: Administrative hospital discharge databases from 10 American states were used to compare knee, hip, and shoulder arthroplasty rates from 1991 to 2005 in patients with SLE and in patients with no inflammatory or autoimmune conditions. Results: Arthroplasties were performed on patients with SLE (n = 4253) and patients with noninflammatory conditions (n = 2,762,660). Arthroplasty rates for patients with noninflammatory conditions almost doubled from 1991 to 2005 (124.5 cases/100,000 persons vs 247.5/100,000; p < 0.001). A similar trend was observed for SLE (0.17/100,000 vs 0.38/100,000; p < 0.001). The mean age at arthroplasty in patients with noninflammatory conditions decreased (71.5 ± 11.8 vs 69.0 ± 12.0; p < 0.001), whereas the mean age in patients with SLE increased (47.3 ± 17.0 vs 56.8 ± 16.0; p < 0.001). When stratified by age and sex, arthroplasty in cases of SLE increased in all groups except for women < 44 years old. In 1991, osteonecrosis accounted for 53% and osteoarthritis (OA) 23% of cases of SLE; by 2005 this relationship had reversed, with osteonecrosis accounting for 24% and OA 61% of cases of SLE. Conclusion: From 1991 to 2005, arthroplasty rates increased in patients with SLE in similar proportions to overall joint replacement rates. The age of patients with SLE arthroplasty increased and fewer cases were due to osteonecrosis. These data suggest significant changes are occurring - patients with SLE are now living long enough to develop OA and are healthy enough to undergo elective surgery.

UR - http://www.scopus.com/inward/record.url?scp=84899763165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899763165&partnerID=8YFLogxK

U2 - 10.3899/jrheum.130617

DO - 10.3899/jrheum.130617

M3 - Article

C2 - 24692528

AN - SCOPUS:84899763165

VL - 41

SP - 867

EP - 874

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 5

ER -